$OVID Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ovid Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ovid Therapeutics Inc.. Get notifications about new insider transactions in Ovid Therapeutics Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 4.42 | 100,000 | 442,000 | 100,000 | |
May 18 2021 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 3.67 | 1,750 | 6,423 | 1,750 | |
Apr 29 2021 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 3.66 | 44,000 | 161,040 | 44,000 | |
Apr 29 2021 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 3.66 | 44,000 | 161,040 | 44,000 | |
Feb 08 2021 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 7.40 | 75,000 | 555,000 | 75,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Rakhit Amit | President and CMO | Option Exercise | A | 2.82 | 200,000 | 564,000 | 200,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Rakhit Amit | President and CMO | Option Exercise | A | 2.82 | 200,000 | 564,000 | 200,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | A | 2.82 | 650,000 | 1,833,000 | 650,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 2.82 | 100,000 | 282,000 | 100,000 | |
Dec 21 2020 | OVID | Ovid Therapeutics ... | Daly Timothy | EVP,Finance & Corp. ... | Option Exercise | A | 2.82 | 125,000 | 352,500 | 125,000 | |
Oct 13 2020 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 5.65 | 20,000 | 113,000 | 20,000 | |
Oct 13 2020 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 5.65 | 20,000 | 113,000 | 20,000 | |
Oct 13 2020 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 5.65 | 20,000 | 113,000 | 20,000 | |
Oct 02 2020 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 5.74 | 325,000 | 1,865,500 | 325,000 | |
Sep 01 2020 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | P | 5.84 | 8,488 | 49,570 | 5,792,530 | 5.8 M to 5.8 M (+0.15 %) |
Sep 01 2020 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | P | 5.84 | 8,488 | 49,570 | 5,792,530 | 5.8 M to 5.8 M (+0.15 %) |
Jun 23 2020 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 7.40 | 50,000 | 370,000 | 50,000 | |
Jun 08 2020 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 5.29 | 13,250 | 70,093 | 13,250 | |
Jun 08 2020 | OVID | Ovid Therapeutics ... | Friedman Bart | Director | Option Exercise | A | 5.29 | 13,250 | 70,093 | 13,250 | |
Jun 08 2020 | OVID | Ovid Therapeutics ... | Duncan Barbara Gayle | Director | Option Exercise | A | 5.29 | 13,250 | 70,093 | 13,250 | |
Jun 08 2020 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 5.29 | 13,250 | 70,093 | 13,250 | |
Jan 02 2020 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 4.15 | 75,000 | 311,250 | 75,000 | |
Dec 20 2019 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | A | 4.42 | 600,000 | 2,652,000 | 600,000 | |
Dec 20 2019 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 4.42 | 100,000 | 442,000 | 100,000 | |
Dec 20 2019 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | SVP, General Counse ... | Option Exercise | A | 4.42 | 100,000 | 442,000 | 100,000 | |
Nov 22 2019 | OVID | Ovid Therapeutics ... | TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | Buy | P | 2.50 | 2,000,000 | 5,000,000 | 5,750,000 | 3.8 M to 5.8 M (+53.33 %) |
Nov 21 2019 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 2.76 | 125,000 | 345,000 | 125,000 | |
Nov 15 2019 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 2.43 | 7,437 | 18,072 | 7,437 | |
Nov 15 2019 | OVID | Ovid Therapeutics ... | Friedman Bart | Director | Option Exercise | A | 2.43 | 7,437 | 18,072 | 7,437 | |
Nov 15 2019 | OVID | Ovid Therapeutics ... | Duncan Barbara Gayle | Director | Option Exercise | A | 2.43 | 7,437 | 18,072 | 7,437 | |
Nov 15 2019 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 2.43 | 7,437 | 18,072 | 7,437 | |
Nov 04 2019 | OVID | Ovid Therapeutics ... | Rakhit Amit | President and CMO | Option Exercise | A | 2.46 | 75,000 | 184,500 | 75,000 | |
Nov 04 2019 | OVID | Ovid Therapeutics ... | Daly Timothy | EVP,Finance & Corp. ... | Option Exercise | A | 2.46 | 25,000 | 61,500 | 25,000 | |
Oct 10 2019 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | P | 2.50 | 60,000 | 150,000 | 4,736,529 | 4.7 M to 4.7 M (+1.28 %) |
Aug 02 2019 | OVID | Ovid Therapeutics ... | Friedman Bart | Director | Option Exercise | A | 1.65 | 5,813 | 9,591 | 5,813 | |
Jun 10 2019 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 1.60 | 5,813 | 9,301 | 5,813 | |
Jun 10 2019 | OVID | Ovid Therapeutics ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.60 | 5,813 | 9,301 | 5,813 | |
Jun 10 2019 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 1.60 | 5,813 | 9,301 | 5,813 | |
Apr 08 2019 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | SVP, General Counse ... | Option Exercise | A | 1.92 | 125,000 | 240,000 | 125,000 | |
Apr 03 2019 | OVID | Ovid Therapeutics ... | During Matthew | Director | Option Exercise | A | 1.76 | 75,000 | 132,000 | 75,000 | |
Feb 28 2019 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Buy | P | 2.02 | 10,000 | 20,210 | 20,000 | 10 K to 20 K (+100.00 %) |
Feb 26 2019 | OVID | Ovid Therapeutics ... | Rakhit Amit | CMO and PMO | Option Exercise | A | 1.89 | 125,000 | 236,250 | 125,000 | |
Feb 26 2019 | OVID | Ovid Therapeutics ... | Daly Timothy | SVP,Finance & Corp. ... | Option Exercise | A | 1.89 | 50,000 | 94,500 | 50,000 | |
Feb 26 2019 | OVID | Ovid Therapeutics ... | Ward Ana | SVP and General Cou ... | Option Exercise | A | 1.89 | 40,000 | 75,600 | 40,000 | |
Feb 26 2019 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 1.89 | 75,000 | 141,750 | 75,000 | |
Feb 26 2019 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | A | 1.89 | 250,000 | 472,500 | 250,000 | |
Feb 26 2019 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | P | 2.00 | 75,000 | 150,000 | 4,676,529 | 4.6 M to 4.7 M (+1.63 %) |
Feb 26 2019 | OVID | Ovid Therapeutics ... | During Matthew | President and CSO | Option Exercise | A | 1.89 | 70,000 | 132,300 | 70,000 | |
Aug 29 2018 | OVID | Ovid Therapeutics ... | Ward Ana | SVP and General Cou ... | Option Exercise | A | 6.40 | 11,250 | 72,000 | 11,250 | |
Aug 29 2018 | OVID | Ovid Therapeutics ... | Daly Timothy | SVP,Finance & Corp. ... | Option Exercise | A | 6.40 | 11,250 | 72,000 | 11,250 | |
Aug 29 2018 | OVID | Ovid Therapeutics ... | Rakhit Amit | CMO and PMO | Option Exercise | A | 6.40 | 70,000 | 448,000 | 70,000 | |
Aug 29 2018 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 6.40 | 22,500 | 144,000 | 22,500 | |
Aug 16 2018 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Buy | P | 6.23 | 10,000 | 62,300 | 10,000 | 0 to 10 K |
Aug 16 2018 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Buy | P | 6.23 | 10,000 | 62,300 | 10,000 | 0 to 10 K |
Aug 16 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Buy | P | 6.49 | 5,000 | 32,442 | 5,000 | 0 to 5 K |
Aug 16 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Buy | P | 6.49 | 5,000 | 32,442 | 5,000 | 0 to 5 K |
Jun 08 2018 | OVID | Ovid Therapeutics ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 8.12 | 5,813 | 47,202 | 5,813 | |
Jun 08 2018 | OVID | Ovid Therapeutics ... | Friedman Bart | Director | Option Exercise | A | 8.12 | 5,813 | 47,202 | 5,813 | |
Jun 08 2018 | OVID | Ovid Therapeutics ... | Duncan Barbara Gayle | Director | Option Exercise | A | 8.12 | 5,813 | 47,202 | 5,813 | |
Jun 08 2018 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 8.12 | 5,813 | 47,202 | 5,813 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | Werber Yaron | CBO, CFO, Sec. and ... | Option Exercise | A | 9.18 | 131,000 | 1,202,580 | 131,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | Ward Ana | SVP and General Cou ... | Option Exercise | A | 9.18 | 20,000 | 183,600 | 20,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | Rakhit Amit | CMO and PMO | Option Exercise | A | 9.18 | 95,000 | 872,100 | 95,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | A | 9.18 | 290,000 | 2,662,200 | 290,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 9.18 | 30,000 | 275,400 | 30,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | During Matthew | President and CSO | Option Exercise | A | 9.18 | 110,000 | 1,009,800 | 110,000 | |
Jan 23 2018 | OVID | Ovid Therapeutics ... | Daly Timothy | SVP,Finance & Corp. ... | Option Exercise | A | 9.18 | 30,000 | 275,400 | 30,000 | |
Sep 06 2017 | OVID | Ovid Therapeutics ... | Ward Ana | SVP and General Cou ... | Option Exercise | A | 8.38 | 95,000 | 796,100 | 95,000 | |
Aug 28 2017 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | P | 7.15 | 15,334 | 109,638 | 4,601,529 | 4.6 M to 4.6 M (+0.33 %) |
Jun 15 2017 | OVID | Ovid Therapeutics ... | Duncan Barbara Gayle | Director | Option Exercise | A | 13.91 | 11,627 | 161,732 | 11,627 | |
May 10 2017 | OVID | Ovid Therapeutics ... | Werber Yaron | CBO, CFO, Sec. and ... | Option Exercise | A | 8.50 | 93,022 | 790,687 | 93,022 | |
May 10 2017 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | C | 0.00 | 35,461 | 0 | 0 | |
May 10 2017 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | C | 0.00 | 400,150 | 0 | 0 | |
May 10 2017 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | C | 0.00 | 35,461 | 0 | 35,461 | 0 to 35.5 K |
May 10 2017 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Buy | C | 0.00 | 400,150 | 0 | 4,586,195 | 4.2 M to 4.6 M (+9.56 %) |
May 10 2017 | OVID | Ovid Therapeutics ... | During Matthew | President and CSO | Option Exercise | C | 0.00 | 28,245 | 0 | 0 | |
May 10 2017 | OVID | Ovid Therapeutics ... | During Matthew | President and CSO | Buy | C | 0.00 | 28,245 | 0 | 4,307,314 | 4.3 M to 4.3 M (+0.66 %) |
May 10 2017 | OVID | Ovid Therapeutics ... | Daly Timothy | VP, Finance & Corp. ... | Option Exercise | A | 8.50 | 46,510 | 395,335 | 46,510 |
Page: 1